Gw Henssler & Associates Ltd
Source: SEC Form 13F · as of Mar 2026Gw Henssler & Associates Ltd holds 18 biotech & pharma companies tracked by BioSniper, totaling $130.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$130.6M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 181,047 | $21.8M |
| AMGNAMGEN INC | 56,962 | $20.0M |
| IDXXIDEXX LABORATORIES INC /DE | 34,816 | $19.6M |
| NVSNovartis AG | 125,512 | $19.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 23,930 | $18.5M |
| PMPhilip Morris International Inc | 107,376 | $17.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 20,640 | $9.2M |
| LLYELI LILLY & Co | 883 | $812K |
| MCKMcKesson Corporation | 784 | $678K |
| JNJJOHNSON & JOHNSON | 2,422 | $592K |
| UTHRUNITED THERAPEUTICS Corp | 718 | $426K |
| PFEPFIZER INC | 13,050 | $366K |
| ABBVAbbVie Inc. | 1,646 | $358K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,191 | $322K |
| ABTABBOTT LABORATORIES | 2,816 | $289K |
| NVONovo Nordisk A/S | 7,450 | $274K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,662 | $257K |
| ALKSAlkermes plc. | 6,370 | $225K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.